Cargando…
Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
Cancer treatment with either standard chemotherapy or targeted agents often results in the emergence of drug-refractory cell populations, ultimately leading to therapy failure. The biological features of drug resistant cells are largely overlapping with those of cancer stem cells and include heterog...
Autores principales: | De Angelis, Maria Laura, Francescangeli, Federica, La Torre, Filippo, Zeuner, Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636659/ https://www.ncbi.nlm.nih.gov/pubmed/31355143 http://dx.doi.org/10.3389/fonc.2019.00626 |
Ejemplares similares
-
Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution
por: Francescangeli, Federica, et al.
Publicado: (2023) -
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
por: De Angelis, Maria Laura, et al.
Publicado: (2019) -
Analysis of Dormancy-Associated Transcriptional Networks Reveals a Shared Quiescence Signature in Lung and Colorectal Cancer
por: Cuccu, Adriano, et al.
Publicado: (2022) -
Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy
por: Baram, Tamir, et al.
Publicado: (2021) -
COVID-19–Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse?
por: Francescangeli, Federica, et al.
Publicado: (2020)